KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 217 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$1,755,000
+30.9%
17,3920.0%0.03%
+28.6%
Q1 2015$1,341,000
+45.0%
17,3920.0%0.02%
+40.0%
Q4 2014$925,000
+13.2%
17,3920.0%0.02%0.0%
Q3 2014$817,000
-24.6%
17,3920.0%0.02%
-16.7%
Q2 2014$1,083,00017,3920.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders